U.S. Department of Justice Attorney General News Update

You are subscribed to Attorney General News for U.S. Department of Justice. This information has recently been updated, and is now available.

 

Attorney General Bondi, Director Patel Statements Regarding Indictment of Former FBI Director James Comey

09/25/2025 08:00 AM EDT

Today, a federal grand jury has charged former FBI Director James Comey with serious crimes related to the disclosure of sensitive information.

---

     

---

You have received this e-mail because you have asked to be notified of changes to the U.S. Department of Justice website. GovDelivery is providing this service on behalf of the Department of Justice 950 Pennsylvania Ave., NW · Washington, DC 20530 · 202-514-2000 and may not use your subscription information for any other purposes.

Manage your Subscriptions | Department of Justice Privacy Policy  | GovDelivery Privacy Policy

 

U.S. Department of Justice DOJ Press Releases & News Update

You are subscribed to DOJ Press Releases & News for U.S. Department of Justice. This information has recently been updated, and is now available.

 

Attorney General Bondi, Director Patel Statements Regarding Indictment of Former FBI Director James Comey

09/25/2025 08:00 AM EDT

Today, a federal grand jury has charged former FBI Director James Comey with serious crimes related to the disclosure of sensitive information.

---

     

---

You have received this e-mail because you have asked to be notified of changes to the U.S. Department of Justice website. GovDelivery is providing this service on behalf of the Department of Justice 950 Pennsylvania Ave., NW · Washington, DC 20530 · 202-514-2000 and may not use your subscription information for any other purposes.

Manage your Subscriptions | Department of Justice Privacy Policy  | GovDelivery Privacy Policy

 

U.S. Department of Justice Civil Division Press Releases Update

You are subscribed to Civil Division Press Releases for U.S. Department of Justice. This information has recently been updated, and is now available.

More Than Two Million Illicit Vaping Products Seized in Nationwide Sweep

09/25/2025 08:00 AM EDT

The Justice Department, together with the U.S. Food and Drug Administration (FDA), announced today that recent actions targeting unauthorized flavored e-cigarettes, or vapes, resulted in the seizure of more than 2.1 million illicit vaping products taken from five distributors and six retailers across seven different states.

The Department of Justice Creates New Civil Division Enforcement & Affirmative Litigation Branch

09/25/2025 08:00 AM EDT

The Department of Justice has announced the creation of a new office within the Civil Division — the Enforcement & Affirmative Litigation Branch — dedicated to safeguarding public health and safety through proactive enforcement and high-impact affirmative litigation.

---

     

---

You have received this e-mail because you have asked to be notified of changes to the U.S. Department of Justice website. GovDelivery is providing this service on behalf of the Department of Justice 950 Pennsylvania Ave., NW · Washington, DC 20530 · 202-514-2000 and may not use your subscription information for any other purposes.

Manage your Subscriptions | Department of Justice Privacy Policy  | GovDelivery Privacy Policy

 

U.S. Department of Justice DOJ Press Releases & News Update

You are subscribed to DOJ Press Releases & News for U.S. Department of Justice. This information has recently been updated, and is now available.

 

The Department of Justice Creates New Civil Division Enforcement & Affirmative Litigation Branch

09/25/2025 08:00 AM EDT

The Department of Justice has announced the creation of a new office within the Civil Division — the Enforcement & Affirmative Litigation Branch — dedicated to safeguarding public health and safety through proactive enforcement and high-impact affirmative litigation.

---

     

---

You have received this e-mail because you have asked to be notified of changes to the U.S. Department of Justice website. GovDelivery is providing this service on behalf of the Department of Justice 950 Pennsylvania Ave., NW · Washington, DC 20530 · 202-514-2000 and may not use your subscription information for any other purposes.

Manage your Subscriptions | Department of Justice Privacy Policy  | GovDelivery Privacy Policy

 

U.S. Department of Justice Consumer Protection Update

You are subscribed to Consumer Protection for U.S. Department of Justice. This information has recently been updated, and is now available.

More Than Two Million Illicit Vaping Products Seized in Nationwide Sweep

09/25/2025 08:00 AM EDT

The Justice Department, together with the U.S. Food and Drug Administration (FDA), announced today that recent actions targeting unauthorized flavored e-cigarettes, or vapes, resulted in the seizure of more than 2.1 million illicit vaping products taken from five distributors and six retailers across seven different states.

---

     

---

You have received this e-mail because you have asked to be notified of changes to the U.S. Department of Justice website. GovDelivery is providing this service on behalf of the Department of Justice 950 Pennsylvania Ave., NW · Washington, DC 20530 · 202-514-2000 and may not use your subscription information for any other purposes.

Manage your Subscriptions | Department of Justice Privacy Policy  | GovDelivery Privacy Policy

 

Biotech Breakthrough: NanoViricides Advances Dual-Action Drug Into Trials

Start your research now. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

Start your research now. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

A message from SCD Media LLC

NV-387 by NanoViricides: A Revolutionary Therapy That Could Prevent Cancer Recurrence While Battling Deadly Viruses—Phase II Trials Underway! NanoViricides, Inc. (NYSE American: NNVC) is at the forefront of a potential medical revolution with its lead drug NV-387, now advancing into Phase II clinical trials. NV-387 is not just a powerful broad-spectrum antiviral—it may also prevent the recurrence of metastatic cancer in patients in remission! Research shows that viral infections, including COVID-19, Influenza, RSV, and measles, can awaken dormant cancer cells, driving metastasis. NV-387 works on two fronts: it attacks the virus while reducing harmful inflammation, particularly IL-6 cytokines, which studies link to cancer cell reactivation. In preclinical studies, NV-387 protected lungs from lethal viral infections while dramatically lowering inflammatory markers, outperforming existing antivirals like Tamiflu and Xofluza. This means NV-387 has unique first-in-class potential, combining lifesaving antiviral efficacy with groundbreaking cancer-prevention effects. The implications for patients and the market are massive. With viral infections surging globally and no therapy currently addressing both viral threats and the risk of metastatic cancer recurrence, NNVC’s NV-387 is positioned to meet a critical unmet medical need. NanoViricides’ exclusive nanoviricide™ platform technology ensures viruses cannot escape, even as new variants emerge, giving the drug a rare competitive edge. This is a company pioneering dual-benefit therapies that could transform antiviral treatment and cancer care simultaneously. With Phase II trials on the horizon, the clinical, commercial, and societal potential of NV-387 is extraordinary. Discover how NV-387’s dual mechanism and unmatched preclinical data make NanoViricides a company poised for transformative impact—financially and medically.

This is a paid advertisement provided to customers of Schaeffer's Investment Research. Although we have sent you this email, Schaeffer's does not necessarily endorse this product nor is it responsible for the content of this advertisement. Schaeffer's makes no guarantee or warranty about what is advertised above. To stop receiving these emails, unsubscribe. Schaeffer's Investment Research 5151 Pfeiffer Road, Suite 450 Cincinnati, Ohio 45242

Forget ChatGPT, use this stock market AI instead

Dear Reader, You've probably heard about ChatGPT. Heck, maybe you even use it. But have you heard about TradeSmithGPT? It's a breakthrough AI system that can identify the timeframe a stock is likely to soar… As well as the percentage return a stock is set to produce within that timeframe… Allowing you to get in ahead of potential stock market moves before they play out. This is something that millions of people have been dreaming about for decades... And it is now possible thanks to the ever-growing power of Artificial Intelligence. This AI has already identified opportunities for returns like: An 8% move on Warby Parker in 6 days… A 26% return on United Airlines in 18 days… A 42% return on Doximity in 2 days… The genius who developed this stock market AI just broke down exactly how it works and how everyday Americans can start using it for the chance to identify winning trades. If you haven't seen this yet, click here to get all the info. Michael Salvatore Editor, TradeSmith Daily To ensure that you continue to receive marketing emails from TradeSmith, please add info@exct.tradesmith.com to your address book. If you no longer want to receive marketing emails from TradeSmith, please click here to unsubscribe. If you have any questions, please don't hesitate to contact Customer Service at support@tradesmith.com or by calling 1-866-385-2076. © 2025 TradeSmith, LLC. All Rights Reserved. 1125 N. Charles Street, Baltimore, MD 21201 Terms of Use  |  Privacy Policy  |  Unsubscribe

Fed Shockwave Live Summit

Fed Shockwave Live Summit ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

WEDNESDAY, SEPTEMBER 24 AT 2 P.M. ET You're In! Your Fed Shockwave LIVE Summit Access Details Bryan Bottarelli, Head Trade Tactician Hey there, Congrats — you're confirmed for the Fed Shockwave LIVE Summit. The next 90 days could set us up for the most profitable trades we've seen all year. During this live event, you'll see exactly how our trading strategy has helped traders flip volatile days… Into HUGE overnight wins! Here's what you'll learn in this special online event: How we've turned down market days into overnight doubles (and more!) Why a simple after-hours trade can outperform weeks or months of "buy and hold" The exact trigger we wait for (and see the 10 years of historical data showing it has 96% accuracy in October) Why the next 90 days could be your most profitable quarter yet! There are three things that I recommend you do between now and the live summit on Wednesday, September 24th @ 2 p.m. ET... Upgrade your virtual seat to VIP Status FOR FREE to unlock special VIP upgrades and important updates about the LIVE summit.  (Click Here To Claim Your FREE Upgrade!) Pay attention to your email for important event information that I'll be sharing leading up to the event.  Save this event to your calendar so you don't miss a single moment of this special live trading summit... Save These Event Details:  📅 Date: Wednesday September 24 ⏰ Time: 2 p.m. ET 📍 Location: https://mta-live.com  Mark Your Calendar! If you've ever wanted a simple, repeatable, data-driven trading edge… One that could give you a statistical advantage … in bull and bear markets… Clear your schedule and make sure you join us LIVE. We'll see you there! Yours in smart speculation, Bryan Bottarelli, Head Trade Tactician Monument Traders Alliance Monument Traders Alliance, LLC You are receiving this email because you signed up to attend the Fed Shockwave Live Summit. To stop receiving special invitations and offers from the Fed Shockwave Live Summit, please click here. Please note: This will not impact the fulfillment of your subscription in any way. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. Website | Privacy Policy | Whitelist Us To cancel by mail or for any other subscription issues, write us at: Fed Shockwave Live Summit | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 800.507.1399 | International: +1.443.353.4977 © 2025 Monument Traders Alliance, LLC All Rights Reserved Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Monument Traders Alliance, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.